{
    "title": "111_hr2769",
    "content": "The \"Commercializing Small Business Research and Development Act\" focuses on promoting research and development projects with commercial potential. It includes energy-related and rare disease research topics for special consideration under the SBIR program. The Small Business Act is amended to include pressing research priorities and references to reports by the National Academy of Sciences and the National Institutes of Health on sustainability, energy, and rare diseases research activities. The Small Business Act is amended to include references to reports by the National Academy of Sciences and the National Institutes of Health on rare diseases research activities and transportation and infrastructure. SEC. 4. NANOTECHNOLOGY-RELATED RESEARCH TOPICS. The Small Business Act is amended to include the national nanotechnology strategic plan in reports by the National Science and Technology Council Committee on Technology. The amendments apply to both SBIR and STTR programs. The Small Business Act is amended to include the national nanotechnology strategic plan in reports by the National Science and Technology Council Committee on Technology, focusing on areas of nanotechnology identified in the plan. SEC. 5. CLARIFYING THE DEFINITION OF ``PHASE THREE''. This section of the Small Business Act is amended to define \"Phase III\" as work that builds upon prior SBIR funding agreements. Additionally, the term \"commercialization\" is defined as the process of developing marketable products or services for sale in government or commercial markets. SEC. 6. AGENCY RESEARCH GOALS. Section 9 of the Small Business Act is amended to require Federal agencies with SBIR programs awarding over $5 billion in contracts to establish annual goals for commercializing SBIR-funded projects, including specific goals for third phase funding and project success rates. The Small Business Act is amended to require Federal agencies with SBIR programs awarding over $5 billion in contracts to establish annual goals for commercializing SBIR-funded projects. Agencies must submit goals and data on project integration and funding received to the Committees on Small Business of the House of Representatives and the Senate. Federal agencies with SBIR programs awarding over $5 billion in contracts must establish annual goals for commercializing SBIR-funded projects. They are required to submit data on the extent to which the goals were met and the methodology used to collect such data to the Committees on Small Business of the House of Representatives and the Senate. Federal agencies with SBIR programs awarding over $5 billion in contracts must establish annual goals for commercializing SBIR-funded projects. They are required to submit data on the extent to which the goals were met and the methodology used to collect such data to the Committees on Small Business of the House of Representatives and the Senate. Additionally, SEC. 7 focuses on commercialization programs. Section 9 of the Small Business Act is amended to include a commercialization program supporting SBIR awardees to the third phase. Activities may include partnership databases, conferences, mentoring, private investment requirements, jumbo awards, helpdesks, and transition assistance programs. Agencies must analyze these activities in their annual reports. The Small Business Act is amended to include a commercialization program supporting SBIR awardees in the third phase. The Administrator may transfer funds to agencies for their commercialization programs upon petition. Rules for transfers must be established within 90 days of enactment. Authorization of appropriations is also included. The Small Business Act is amended to authorize appropriations of $27,500,000 annually for the Administrator to carry out commercialization programs. Agencies can use up to 1% of SBIR funds for program expenses, excluding salaries and federal employee costs."
}